Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Liabilities and Shareholders Equity: 2013-2018

Historic Liabilities and Shareholders Equity for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $10.6 million.

  • Armata Pharmaceuticals' Liabilities and Shareholders Equity fell 22.94% to $10.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $47.9 million, marking a year-over-year decrease of 21.95%. This contributed to the annual value of $11.1 million for FY2017, which is 38.64% down from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Liabilities and Shareholders Equity is $10.6 million, which was down 9.39% from $11.7 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Liabilities and Shareholders Equity's 5-year high stood at $38.6 million during Q1 2015, with a 5-year trough of $10.6 million in Q3 2018.
  • Over the past 3 years, Armata Pharmaceuticals' median Liabilities and Shareholders Equity value was $14.4 million (recorded in 2018), while the average stood at $17.5 million.
  • In the last 5 years, Armata Pharmaceuticals' Liabilities and Shareholders Equity climbed by 10.05% in 2015 and then tumbled by 49.39% in 2017.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Liabilities and Shareholders Equity stood at $28.6 million in 2014, then rose by 10.05% to $31.5 million in 2015, then slumped by 42.36% to $18.2 million in 2016, then plummeted by 38.64% to $11.1 million in 2017, then dropped by 22.94% to $10.6 million in 2018.
  • Its last three reported values are $10.6 million in Q3 2018, $11.7 million for Q2 2018, and $14.4 million during Q1 2018.